Delivery Order SPE2DB24D2106-SPE2DB24FAUZC

Award Date 9/20/24
Potential Completion Date 10/11/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of 4,568,160,321 units of the prescription drug Promacta 25 mg tablets. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This is a delivery order award under contract SPE2DB24D2106 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $21,727.74 firm fixed-price contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including PROMACTA 50 mg tablets. This award is not associated with any set-aside program. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB24FATWX, with DLA valued up to $4,999,999 through 2025...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military and government healthcare facilities. The contract has an award value of $37,053.68 and a completion date of April 10, 2024. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract, contract #SPE2DB, which has a ceiling value of up to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award, valued at $37,053.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $31,848.54, is a firm fixed-price delivery order for a Prime Vendor Pharmaceutical program supporting the DLA's Medical Supply Chain division. It covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies. The award, valued at $16,961.90, is a delivery order under the DLA's SPE2DX24FENXH program, which is an indefinite delivery contract vehicle that enables DLA to issue firm fixed-price orders for various pharmaceutical items to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award, valued at $7,333.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders to DMS Pharmaceutical Group for a...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUZC
    Delivery Order

This federal contract award, valued at $3,997.21, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order with no set-aside designation, falling under the DLA's SPE2DB program, which is a $499,999,999 indefinite delivery contract that covers a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. Through this contract, DMS Pharmaceutical Group will provide the 30-count bottle of the drug Promacta 25 mg tablet to the DLA. The contract has an ultimate completion date of October 11, 2024.

Generated 12/20/24, 9:38 AM